Live feed08:00:00·1129dPRReleasevia QuantisnowApollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on NasdaqByQuantisnow·Wall Street's wire, on your screen.JMAC· Maxpro Capital Acquisition Corp.Industrials
